Company Description
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.
The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.
The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.
The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Country | United States |
Founded | 2023 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 20,098 |
CEO | Bryan Hanson |
Contact Details
Address: 3M Center, Building 275-6W Saint Paul, Minnesota 55144 United States | |
Phone | 651-733-1110 |
Website | solventum.com |
Stock Details
Ticker Symbol | SOLV |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001964738 |
CUSIP Number | 83444M101 |
ISIN Number | US83444M1018 |
Employer ID | 92-2008841 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Bryan C. Hanson | Chief Executive Officer and Director |
Wayde D. McMillan | Chief Financial Officer |
Mary T. Wilcox | Senior Vice President, Controller and Chief Accounting Officer |
Amy Landucci | Chief Information and Digital Officer |
Marcela A. Kirberger | Chief Legal Affairs Officer and Corporate Secretary |
Sanjiv Arora | Chief Strategy and Corporate Development Officer |
Tammy L. Gomez | Chief Human Resources Officer |
Paul S. Harrington | Chief Supply Chain Officer |
Karim Mansour | President of Dental Solutions |
Garri Garrison | President of Health Information Systems |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 15, 2024 | S-4 | Filing |
Nov 14, 2024 | SCHEDULE 13G | Filing |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 |
Nov 8, 2024 | 10-Q | Quarterly Report |
Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 7, 2024 | 8-K | Current Report |
Nov 5, 2024 | 8-K | Current Report |
Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Oct 24, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |